IOXILAN - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for ioxilan and what is the scope of freedom to operate?
Ioxilan
is the generic ingredient in two branded drugs marketed by Guerbet and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for IOXILAN
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 48 |
| DailyMed Link: | IOXILAN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for IOXILAN
US Patents and Regulatory Information for IOXILAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Guerbet | OXILAN-350 | ioxilan | INJECTABLE;INJECTION | 020316-002 | Dec 21, 1995 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Guerbet | OXILAN-300 | ioxilan | INJECTABLE;INJECTION | 020316-001 | Dec 21, 1995 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for IOXILAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Guerbet | OXILAN-300 | ioxilan | INJECTABLE;INJECTION | 020316-001 | Dec 21, 1995 | 4,954,348 | ⤷ Start Trial |
| Guerbet | OXILAN-350 | ioxilan | INJECTABLE;INJECTION | 020316-002 | Dec 21, 1995 | 4,954,348 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
